Aetiology and Treatment of Sleep Disturbances During Perimenopause and Postmenopause
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 15 (6) , 445-452
- https://doi.org/10.2165/00023210-200115060-00003
Abstract
The sudden and predictable cessation of ovarian endocrinological function at menopause results in a marked decrease of endogenous estrogen and progestogen secretion. In addition to cessation of menstruation, a wide range of biological functions, including sleep, are affected. Sleep disturbances are more common in women than in men and their incidence increases with age. There are 2 distinct mechanisms by which menopause is known to affect sleep quality. One is menopausal insomnia, which can be considered as part of the symptomatology of the climacterium. Another is sleep-disordered breathing, where impairment of sleep quality is secondary to sleep apnoea or partial upper airway obstruction during sleep. The former is effectively controlled with conventional estrogen replacement therapy, whereas the latter could potentially be improved with progestogens. Many age-related conditions without a direct link with the menopause should also be considered when treating postmenopausal sleep disorders.Keywords
This publication has 54 references indexed in Scilit:
- Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiencyObstetrics & Gynecology, 2000
- Letter to the EditorJournal of Sleep Research, 1999
- Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal womenFertility and Sterility, 1999
- The menopauseThe Lancet, 1999
- When does estrogen replacement therapy improve sleep quality?American Journal of Obstetrics and Gynecology, 1998
- Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot studyClinical Therapeutics, 1997
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- Clinical Presentation and Neuropharmacology of Restless Legs SyndromeClinical Neuropharmacology, 1987
- Sleep Apnea, Hypopnea and Oxygen Desaturation in Normal SubjectsNew England Journal of Medicine, 1979